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Aim: The aim of the study was to analyse the reason of elevated hemoglobin concentra-
tion in childhood. Background: Elevated hemoglobin concentration is a rare abnormality
during childhood. There are disorders of hereditary or acquired hyperproliferations of red
cells or pseudo high hemoglobin conditions. Materials and methods: We present
3 asymptomatic children in whom high hemoglobin concentration was diagnosed by
a family doctor. Results: Given that the iron concentration was elevated, genetic testing
for HFE mutation was carried out. Conclusion: Patients presented with HFE mutation
might have an increased hemoglobin production.
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In the diagnosis of elevated hemoglobin concentration
primary, secondary as well as pseudo high hemoglobin
concentration should be considered as possible causes [1, 2].
The underlying causes of increased red blood cell prolifera-
tion can be attributed to hereditary or acquired diseases.
Hereditary primary disease is characterized by a defect in
the erythroid progenitor cells which causes an abnormal
response to cytokines that regulate the growth and matura-
tion of the erythroid line – erythropoetin receptor gene* Corresponding author at: Department of Pediatrics, Hematology an
Gdańsk, Poland. Tel.: +48 583492860; fax: +48 583492863.
E-mail address: bakaczor@gumed.edu.pl (B. Kaczorowska-Hac).
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0031-3939/© 2014 Polish Pediatric Society. Published by Elsevier Urbanmutations (familial erythrocytosis type 1). Hereditary secon-
dary disease includes types 2, 3 and 4 familial erythrocytosis
whose underlying causes are mutations of genes regulating
the synthesis of erythropoetin such as the von Hippel
Lindau factor (Chuvash polycythemia), PHD2 factor and
hypoxia inducible factor HIF-2 alpha. In addition, the heredi-
tary secondary group also includes hemoglobinopathies
such as Luton hemoglobinopathy in which a higher afﬁnity
for oxygen by abnormal hemoglobin stimulates compensa-
tory overproduction of cells and enhanced hemoglobin
synthesis [1, 3–7]. Polycythemia vera is classiﬁed as
a myeloproliferative disease whose main underlying factord Oncology Medical University of Gdansk, ul. Debinki 7, 80-211
 & Partner Sp. z o.o. Open access under CC BY-NC-ND license.
Table I – Morphology, iron status and HFE mutation in
diagnosed children
Patient MJ MK AG
Gender M M F
Age (years) 17 16 12
Hemoglobin (g/dl) 18.8 18.0 15.4
Erythrocytes (1012) 5.99 5.51 5.27
Hematocrit (%) 52.7 52.2 43.3
MCV (Fl) 88 94.3 82.2
Reticulocytes (%) 1.4 1.4 0.9
Bilirubin (mg/dl) 2.72 1.2 0.96
Iron (mg/dl) 333 284 197
Ferritin (ng/ml) 92.17 121.6 40.43
Transferrin saturation (%) 89% 74% 70%
HFE mutation H63D/zz C282Y/zz C282Y/C282Y
M – boys, F – girls.
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V617F gene [8]. In turn, secondary polycythemia is associated
with an increased production of erythropoietin in the course
of diseases such as cancer, hemangiomas, as well as in
patients with congenital heart diseases or respiratory failure
[9, 10]. Relative increase in hemoglobin concentration is also
observed in states of dehydration, most often in the course of
an infection, gastrointestinal disorders with diarrhea, vomi-
ting and fever [1]. In cases where no identiﬁable cause can be
found it is termed idiopathic polycythemia [1]. Hereditary
hemochromatosis is a metabolic disease in which
a genetically determined defect leads to abnormal iron
homeostasis. Excessive iron absorption from the gastrointes-
tinal tract and uncontrolled release of iron from macrophages
results in body iron overload. Current classiﬁcation distingui-
shes 4 types of hemochromatosis, among which hemochro-
matosis type 1 is the most frequently diagnosed (HFE) [11, 12].
We present here 3 children who underwent diagnoses
because of elevated hemoglobin levels, in whom HFE gene
mutation was conﬁrmed.
Material and methods
The study was conducted in 2 boys aged 17 and 16 and
a 12-year-old girl sent to the clinic for further diagnosis of
elevated levels of hemoglobin, which were discovered
during laboratory assays performed in an outpatient setting,
at the request of the parents. The general condition of all
the children was good and they had no existing complaints.
On physical examination, no deviations from the norm were
found in the 16-year-old boy and 12-year-old girl. The 17-
year-old, however, was found to be obese with a BMI of 32.
A few years earlier due to this condition (abnormal weight),
this patient had undergone endocrinological investigation.
Although abnormal eating habits were identiﬁed as the
major cause, the patient did not follow dietary recommen-
dations given. Laboratory assays performed on him at the
time revealed a hemoglobin concentration on the upper
limit of the norm. Furthermore, additional previously perfor-
med assays also revealed a hemoglobin concentration that
was also on the upper limit of the norm or that periodically
exceeded it. In the analysis of past medical history and
concomitant diseases of the other 2 children there were no
serious ailments noted and they adhered to good dietary
practises. All the children were physically active. Imaging
studies – an abdominal ultrasound and echocardiography –
were performed on all 3 children. The abdominal ultrasound
of the 17-year-old patient revealed a longitudinally enlarged
spleen whereas the echocardiography performed on the girl
revealed residual mitral regurgitation, which was hemody-
namically insigniﬁcant. The remainder of the imaging stu-
dies revealed no deviations from the norm. On further
investigation, a positive family history was noted for the
17-year-old boy and 12-year-old girl. It was noted that the
oldest patients' father had died of heart failure at the age of
42 years, had had a history of poorly managed hypertension,
obesity and nicotinisim. Laboratory assays of the girl's
father preformed beforehand, revealed elevated levels
of serum ferritin and he was awaiting a hematologicalconsultation. All the parents' hemoglobin levels were nor-
mal. None of the children had ever been on any kind of
medication, including iron preparations or vitamins fortiﬁed
with iron. All the patients underwent laboratory assays
which included, a full blood count with reticulocytosis and
microscopic evaluation, alanine concentration, aspartate
and alanine transaminases, bilirubin, creatinine, total pro-
tein, CRP, coagulation proﬁle, HBsAg and anti-HCV antibo-
dies, erythropoietin levels, urinalysis, and capillary blood
gas. Iron metabolism was also assessed by measuring iron
concentration, ferritin and transferrin saturation. In addi-
tion, bone marrow biopsy was carried out on the oldest boy
and girl.
All 3 patients had hematocrit levels that exceeded the
reference value for their age. Hemoglobin concentration was
higher in the oldest boy and girl, while the 16-year-old boys'
levels were on the upper limit of the norm. Furthermore,
the girls' erythrocyte count was elevated whereas reticulo-
cytosis count was within the reference values for all the
patients The 17-year old met the diagnostic criteria accor-
ding to the WHO for polycythemia in man. Hyperbilirubine-
mia was also noted in the oldest boy and a hepatology
consultation was recommended. Iron concentration and
transferrin saturation exceeded the norm in all the children,
while ferritin concentration, transaminases, creatinine and
erythropoietin levels remained within the reference ranges.
The coagulation proﬁle, CRP and capillary blood gas tests
were also within the norm.
HBV and HCV infection was excluded and so were
mononucleosis, cytomegalovirus and toxoplasmosis proto-
zoan. The bone marrow biopsy performed in the oldest boy
and the girl revealed no deviations from the norm. Molecu-
lar studies on the oldest boy excluded a V617F mutation.
The characteristic biochemical parameters of the patients
are listed in Table I. On the basis of diagnostic indications
given in previous publications [13], molecular diagnosis of
type 1 hemochromatosis (HFE mutation) was performed on
the children.
Diagnostic materials – DNA isolated from 200 ml of whole
blood collected in EDTA using High Pure PCR Template
Preparation Kit (Roche) reagents. DNA fragment consisting
of 354 base pairs, which include the H63D and S65C HFE
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pairs, which encompass the C282Y HFE gene region, which
were ampliﬁed using multiplex Real-Time PCR. The geno-
type identiﬁcation was based on melting curve analysis,
using HybProbe probes, based on the speciﬁc melting points
(Tm): Tm for a normal H63 and S65 HFE genotype = 57 8C,
using the 530 nm channel; mutant HFE 63D Tm = 65.5 8C,
mutant HFE 65 8C Tm = 52 8C, normal HFE C282 Tm = 56.5 8C,
using the 640 nm channel; mutant HFE 282Y Tm = 62 8C.
The presence of HFE mutations was conﬁrmed in all the
patients. In the oldest boy a His/Asp phenotype at position
63 of the HFE protein (heterozygous for the HFE gene at
position 187, C/G, H63D), the 16-year old had a Cys/Tyr
phenotype at position 282 of the HFE protein (heterozygous
for the HFE gene at position 845, G/A, C282Y), whereas the
girl was diagnosed with a homozygous mutation in the HFE
282Y (Tyr/Tyr phenotype, homozygous for the HFE gene at
position 845, A/A).
All the patients remain under clinical observation in the
department. Their hemoglobin concentration and erythro-
cyte count are comparable with previous tests.
Discussion
For a preliminary assessment of the hematopoietic system,
the primary diagnostic tool is a full blood count. Elevated
hemoglobin concentrations, as opposed to anemia, are
rarely observed during childhood [1, 2]. In the 3 children
mentioned above, elevated levels of hemoglobin were found
in full blood counts performed without any speciﬁc medical
indication in an outpatient setting. The children did not
report any complaints or infections. Besides obesity in the
oldest boy, there were no variations in their physical
examination. It was noted that in previously performed
laboratory assays, years earlier, hemoglobin concentrations
of the patients were on the upper limit of the norm or
periodically exceeded it, probably due to hydration. The
investigations carried out in the clinic, revealed that the 17-
year-old boys' hemoglobin concentration met the WHO
criteria for the diagnosis of polycythemia in men. A bone
marrow biopsy performed on him was also assessed normal.
Despite elevated hematocrit levels, hemoglobin concentra-
tion and erythrocyte count, the girls bone marrow biopsy
was also assessed as normal. In turn, only the hematocrit
levels exceeded norm in the 16-year-old boy, while hemo-
globin concentration was on the upper limit, the decision
for a bone marrow biopsy was therefore withheld. Diagnosis
for congenital, primary polcythemia was not conducted
because of their different clinical course [3, 5–7]. Acquired
secondary causes of polycythemia were also excluded
because erythropoietin concentration, gas analysis and
echocardiography were normal. Laboratory tests performed
on all the patients revealed abnormal iron metabolism,
which lead to the diagnosis for hemochromatosis [13].
Molecular studies conﬁrmed the presence of HFE mutations
in heterozygous H63D form in the boys and C282Y, C282Y
homozygous form for the girl. Hereditary hemochromatosis
is a genetic disorder, which results in tissue iron overload.
This disorder results in the mutation of proteins controllingiron metabolism, increasing iron absorption and with it
plasma levels, transferrin saturation and iron stores. The
process progresses over time, resulting in permanent
damage to the liver, cardiomyopathy, endocrinopathy, arth-
ropathy and dark skin color in the 4–5 decade of life. Among
HFE gene mutations, the C282Y mutation in homozygous
form is of paramount importance as it is found in 60–96% of
the patients with clinical signs of the disease. In the
heterozygous form, this mutation occurs in approximately
9.2% of the European population. Homozygotes have
a prevalence of 1:200–1:400, and are found mainly in the
northern regions of the continent. As for H63D mutations,
they have been observed in up to 2% of the European
population and are frequently observed in heterozygous
form in the southern countries. Although the hemochroma-
tosis gene is common, expression of clinical signs is rare. It
is believed that their incidence is affected by the presence
of additional, innate and acquired conditions [11, 12].
Thorough diagnosis of elevated iron levels in the develop-
mental age is not widespread practise and publications on
congenital disorders of iron metabolism in the pediatric
population are scarce. According to currently available
knowledge, children with HFE mutations only demonstrate
abnormal biochemical markers of iron levels [13, 14]. In the
patients presented above, the inﬂuence of unstable iron
homeostasis on the modulation of erythropoiesis intensity
by direct or indirect mediators of the metabolic pathways
cannot be excluded [15, 16].
Expertise on congenital hemochromatosis in children is
limited; hence, recording and monitoring of any clinical or
laboratory abnormalities in these patients seems to be
justiﬁed.
Conclusion
HFE mutation via increased iron absorption method might
have an inﬂuence on hemoglobin production.
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